Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 8,925 shares at $39.35 ($352K) on 2014-07-01, disclosed to the SEC on 2014-07-03.
Scheduled sale ($352k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.71 | 2,871 | $111K | 31.5% |
| 2 | $39.35 | 2,484 | $98K | 27.7% |
| 3 | $40.18 | 3,570 | $143K | 40.7% |
| Total | $39.48 avg | 8,925 | $352K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |